Home
 /
Papers
 /
Microbiology
 /
A Protein Antibiotic Inhibits the BAM Complex to Kill Without Cell Entry
Preprint
Open access
Top 1% · Validated by QED

A Protein Antibiotic Inhibits the BAM Complex to Kill Without Cell Entry

Fabian Munder, Matthew Johnson, Imogen Samuels +17 more
September 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2025.09.18.677229
99
%
QED Score
QED Impressions

By demonstrating that protein antibiotics kill Gram-negative pathogens by trapping the BAM complex at the cell surface—no membrane penetration required—this work overturns a foundational premise in antibiotic discovery and defines an engineerable new therapeutic modality.

Run full QED analysis
Read paper
Save

QED claims analysis

Summary

L-type pyocins kill Pseudomonas aeruginosa without cell entry by binding BamA loop 6 at the cell surface and deploying a C-terminal peptide that competitively inhibits the BAM complex through β-strand 1 binding, ultimately causing catastrophic outer membrane disruption and cell death despite rapid cellular stress responses.

See full analysis
Main Claim 1 –

L-type pyocins potently inhibit P. aeruginosa at nanomolar IC50

Supporting evidence

  • Multiple L-type pyocins kill diverse P. aeruginosa clinical isolates
  • BamA loop 6 variation correlates with pyocin susceptibility
  • C-terminal peptide is essential for L-type pyocin activity
Main Claim 2 –

Native P. aeruginosa BAM adopts an outward-open conformation

Main Claim 3 –

L-type pyocins bind BamA loop 6 and deploy C-terminus

Main Claim 4 –

L-type pyocins inhibit BAM via β-strand 1 β-augmentation

Supporting evidence

  • C-terminal peptide requires β-lectin attachment for cytotoxicity
  • Pyocin–BAM inhibition proceeds through a two-step conformational transition

Abstract

Many antibiotics are ineffective against Gram-negative pathogens such as Pseudomonas aeruginosa because they cannot penetrate the bacterial outer membrane. Here, we show that protein antibiotics called L-type pyocins kill P. aeruginosa by inhibiting the β-barrel assembly machinery (BAM) complex at the cell surface, halting outer-membrane protein assembly. Using single-particle cryo-electron microscopy, we show that L-type pyocins bind a surface-exposed region of BamA and deploy a C-terminal peptide that competitively inhibits the BAM complex, demonstrating that cell entry is not required for antibiotic activity. We combine genetics, multi-omics and cryo-electron tomography to show that BAM complex inhibition by L-type pyocins or the peptide antibiotic darobactin triggers a multifaceted transcriptomic, proteomic and morphological response. Despite this, BAM inhibition ultimately leads to a catastrophic loss of membrane integrity and cell death. These results validate BAM as a target for antibiotics that do not enter the cell and define an engineerable system for their development.

Related papers

How the QED Score works

QED Score is an AI-based quality metric for life science research. It rates each paper on two dimensions: originality (is the finding new and important?) and validity (does the evidence support the claims?). Author names and affiliations are removed before scoring. Each manuscript is broken down into its claims and the experiments behind them, and specialized AI agents then examine those claims for statistical rigor, consistency across figures, and contradictions with the existing literature. A verification layer re-checks every issue they flag. Scores are percentile ranks against all papers in the corpus. In a blinded study of papers where QED Score and journal rank disagreed, domain experts sided with QED Score in 75% of cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?